← SynDRA
APTIGANEL
SynDRA canonical compound SYN0003592 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
| Primary target(s) | GRIN1 |
| Mechanism of action | Glutamate receptor antagonist |
All known targets
Mechanisms of action (all sources)
- Glutamate receptor antagonist
Drug classes
- Excitatory Amino Acid Antagonists
- Neuroprotective Agents
Cross-references
Synonyms
- 1-(m-Ethylphenyl)-1-methyl-3-(1-naphthyl)guanidine
- Guanidine, N-(3-ethylphenyl)-N-methyl-N'-1-naphthalenyl-
- aptiganelum
- RefChem:113564
- DTXCID0028406
- Aptiganel [INN]
- 1-(3-ethylphenyl)-1-methyl-2-naphthalen-1-ylguanidine
- 1-(3-ethylphenyl)-1-methyl-3-(naphthalen-1-yl)guanidine
- Lopac-C-4238
- UNII-46475LV84I
- APTIGANEL [MI]
- APTIGANEL [MART.]
- APTIGANEL [WHO-DD]
- Lopac0_000312
- SCHEMBL151144
- SCHEMBL151145
- orb1701185
- SCHEMBL21775476
- SCHEMBL29742194
- SCHEMBL30416816
- SCHEMBL30481113
- CHEBI:135286
- BDBM50043958
- AKOS040747835
- CCG-204407
- SDCCGSBI-0050300.P002
- NCGC00015236-01
- NCGC00015236-02
- NCGC00015236-03
- NCGC00015236-07
- NCGC00162124-01
- DA-50654
- HY-100356
- CS-0018670
- NS00120369
- T26645
- 1-(3-ethylphenyl)-1-methyl-2-(1-naphthyl)guanidine
- BRD-K63919159-003-07-0
Look up APTIGANEL in the interactive SynDRA portal →